HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Amarin Corporation plc (AMRN)
4.98  -0.04  (-0.8%) 10-26 03:47
Open: 5.02 High: 5.0305
Pre.close: 5.02 Low: 4.88
Volume: 2,748,118 Ave vol: 8,765,254
52w High: 26.12 52w Low: 3.36
MA(50): 4.519 MA(200): 6.311
EPS: -0.034 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.amarincorp.com/
Market Cap (M): 1,936
Shares Out (M): 389
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm operates through the development and commercialization of Vascepa segment. The firm's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Technical analysis
Overall: Neutral
MA: Bearish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 6.51 Target 2: 7.60
Resist 1: 5.57 Resist 2: 6.51
Support 1: 4.20 Support 2: 3.36
Company key metrics
Revenue per Share: 1.2546
Net Income per Share: -0.0661
Cash per Share: 1.8818
Book Value per Share: 1.7758
Price to Sales: 15.1759
Price to Book Value: 10.7222
Earnings Yield: -0.0035
Dividend Yield: 0
Debt to Equity: 0.4504
Debt to Assets: 0.3105
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Outperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.